Recent Stock Dip: Tenet Healthcare Corporation has recently experienced a notable dip in stock price, with a reported 3% drop in a single trading session. Discussions on social media highlight concern among investors about this decline, especially following mixed quarterly results that showed revenue and earnings growth but underperformed compared to peers.
Analyst Price Target Adjustment: A prominent analyst firm recently lowered its price target for THC from $233 to $230, though it maintained a buy rating. Social media chatter reflects a mix of cautious optimism, with some users pointing to the stock’s potential for recovery despite short-term bearish patterns like a 'bear flag' mentioned in discussions.
Valuation Debate: There’s growing conversation about THC’s valuation after a 5% pullback over the past month, despite steady fundamentals. On social media, some argue the stock is oversold and poised for a rebound, while others remain wary of broader market pressures impacting healthcare stocks.
Note: This discussion summary was generated from an AI condensation of post data.
Tenet Healthcare Corporation Insider Trading Activity
Tenet Healthcare Corporation insiders have traded $THC stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:
- SAUMYA SUTARIA (CEO) has made 0 purchases and 2 sales selling 78,762 shares for an estimated $15,026,139.
- TAMMY ROMO has made 0 purchases and 6 sales selling 27,500 shares for an estimated $5,563,324.
- R. SCOTT RAMSEY (Principal Accounting Officer) has made 0 purchases and 3 sales selling 13,322 shares for an estimated $2,732,438.
- LISA Y FOO (EVP, Chief Operating Officer) sold 8,000 shares for an estimated $1,436,240
- CHRISTOPHER S. LYNCH has made 0 purchases and 2 sales selling 3,960 shares for an estimated $698,560.
- RICHARD W FISHER sold 2,500 shares for an estimated $521,075
- NADJA WEST sold 2,178 shares for an estimated $430,089
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Tenet Healthcare Corporation Revenue
Tenet Healthcare Corporation had revenues of $5.3B in Q3 2025. This is an increase of 3.18% from the same period in the prior year.
You can track THC financials on Quiver Quantitative's THC stock page.
Tenet Healthcare Corporation Congressional Stock Trading
Members of Congress have traded $THC stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $THC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 2 purchases worth up to $65,000 on 12/10, 09/03 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Tenet Healthcare Corporation Hedge Fund Activity
We have seen 326 institutional investors add shares of Tenet Healthcare Corporation stock to their portfolio, and 319 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EMINENCE CAPITAL, LP added 1,109,450 shares (+inf%) to their portfolio in Q3 2025, for an estimated $225,262,728
- BOSTON PARTNERS added 889,283 shares (+39.4%) to their portfolio in Q3 2025, for an estimated $180,560,020
- CITADEL ADVISORS LLC removed 772,360 shares (-42.2%) from their portfolio in Q3 2025, for an estimated $156,819,974
- AQR CAPITAL MANAGEMENT LLC added 720,160 shares (+62.3%) to their portfolio in Q3 2025, for an estimated $146,221,286
- INVESCO LTD. removed 681,050 shares (-24.3%) from their portfolio in Q3 2025, for an estimated $138,280,392
- GLENVIEW CAPITAL MANAGEMENT, LLC removed 606,326 shares (-20.7%) from their portfolio in Q3 2025, for an estimated $123,108,431
- HOLOCENE ADVISORS, LP removed 584,404 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $118,657,388
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Tenet Healthcare Corporation Government Contracts
We have seen $135,000 of award payments to $THC over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- STERILE PROCESSING SERVICES: $135,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Tenet Healthcare Corporation Analyst Ratings
Wall Street analysts have issued reports on $THC in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/07/2026
- Barclays issued a "Overweight" rating on 11/21/2025
- JP Morgan issued a "Overweight" rating on 11/13/2025
- RBC Capital issued a "Outperform" rating on 10/30/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/29/2025
- Guggenheim issued a "Buy" rating on 10/29/2025
- UBS issued a "Buy" rating on 10/29/2025
To track analyst ratings and price targets for Tenet Healthcare Corporation, check out Quiver Quantitative's $THC forecast page.
Tenet Healthcare Corporation Price Targets
Multiple analysts have issued price targets for $THC recently. We have seen 15 analysts offer price targets for $THC in the last 6 months, with a median target of $230.0.
Here are some recent targets:
- Ryan Langston from TD Cowen set a target price of $230.0 on 01/07/2026
- Stephen Baxter from Wells Fargo set a target price of $229.0 on 01/07/2026
- Jason Cassorla from Guggenheim set a target price of $257.0 on 12/02/2025
- Andrew Mok from Barclays set a target price of $240.0 on 11/21/2025
- Benjamin Rossi from JP Morgan set a target price of $230.0 on 11/13/2025
- David Macdonald from Truist Securities set a target price of $240.0 on 11/03/2025
- Ben Hendrix from RBC Capital set a target price of $252.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
